Growth Metrics

Pacific Biosciences Of California (PACB) Restructuring Costs (2021 - 2023)

Pacific Biosciences Of California has reported Restructuring Costs over the past 2 years, most recently at $63000.0 for Q4 2023.

  • Quarterly results put Restructuring Costs at $63000.0 for Q4 2023, changed N/A from a year ago — trailing twelve months through Dec 2024 was $9.0 million (changed N/A YoY), and the annual figure for FY2023 was $9.0 million, changed.
  • Restructuring Costs for Q4 2023 was $63000.0 at Pacific Biosciences Of California, down from $9.0 million in the prior quarter.
  • Over the last five years, Restructuring Costs for PACB hit a ceiling of $12.0 million in Q3 2021 and a floor of $63000.0 in Q4 2023.